Immunovative Clinical Research Company Profile
Immunovative Clinical Research, founded in 2009 and headquartered in Carlsbad, CA, is a private biopharmaceutical services company specializing in managing clinical trials, regulatory approvals, and expanded access programs based on its intellectual property, which was acquired by Tauriga Sciences in May 2011 after one financing round.
Overview
Immunovative Clinical Research is a provider of biopharmaceutical services. The company manages and conducts clinical trials, obtains regulatory approvals for marketing products based on immunovative intellectual property, and manages an expanded access program.
- Year Founded: 2009
- Status: Acquired/Merged
- Latest Deal Type: M&A
- Financing Rounds: 1
- Primary Industry: Other Pharmaceuticals and Biotechnology
- Headquarters: 2720 West Loker Avenue, Suite Q, Carlsbad, CA 92010, United States
- Acquirer: Tauriga Sciences
FAQs
When was Immunovative Clinical Research founded?
Immunovative Clinical Research was founded in 2009.
Where is Immunovative Clinical Research headquartered?
Immunovative Clinical Research is headquartered in Carlsbad, CA.
What industry is Immunovative Clinical Research in?
Immunovative Clinical Research’s primary industry is Other Pharmaceuticals and Biotechnology.
Is Immunovative Clinical Research a private or public company?
Immunovative Clinical Research is a private company.
Who are Immunovative Clinical Research’s investors?
Immunovative Therapies has invested in Immunovative Clinical Research.
When was Immunovative Clinical Research acquired?
Immunovative Clinical Research was acquired on 19-May-2011.
Who acquired Immunovative Clinical Research?
Immunovative Clinical Research was acquired by Tauriga Sciences.